Log in

688217 Shanghai Rightongene Biotechnology Co. Ltd. SSE · China

Shanghai Rightongene Biotechnology Co. (688217) news

Shanghai Rightongene Biotechnology Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688217, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Shanghai Rightongene Biotechnology Co. news

We have not published a story on Shanghai Rightongene Biotechnology Co. yet. When there is news, it will appear here.

Questions about Shanghai Rightongene Biotechnology Co.

What is the ticker symbol of Shanghai Rightongene Biotechnology Co.?

Shanghai Rightongene Biotechnology Co. Ltd. trades under the ticker 688217 on SSE.

Where is Shanghai Rightongene Biotechnology Co. listed?

Shanghai Rightongene Biotechnology Co. Ltd. is listed on SSE.

Which country or territory is Shanghai Rightongene Biotechnology Co. listed under?

Our directory records Shanghai Rightongene Biotechnology Co. Ltd. under China.

What does Shanghai Rightongene Biotechnology Co. do?

Our directory classifies Shanghai Rightongene Biotechnology Co. Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Shanghai Rightongene Biotechnology Co.?

The ISIN recorded for Shanghai Rightongene Biotechnology Co. Ltd. is CNE100005212.

Does aibio.space cover Shanghai Rightongene Biotechnology Co.?

aibio.space lists Shanghai Rightongene Biotechnology Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Shanghai Rightongene Biotechnology Co.?

Companies in our directory listed in the same country and business area as Shanghai Rightongene Biotechnology Co.: Jiangsu gdk Biotechnology Co., Guangzhou Wondfo Biotech Co., Beijing Wantai Biological Pharmacy Enterprise Co., Nanjing Vazyme Biotech Co., Hualan Biological Engineering, Beijing Luzhu Biotechnology Co..

Investor discussion: Shanghai Rightongene Biotechnology Co.

Members talk about Shanghai Rightongene Biotechnology Co. (688217). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688217 on TradingView.

Listing details

Shanghai Rightongene Biotechnology Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688217, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Shanghai Rightongene Biotechnology Co. Ltd.
Ticker
688217
Listing
SSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE100005212
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.